Skip to main content

SL Science Holding Ltd

SLBT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0002070534

No open-market purchases or sales by SL Science Holding Ltd insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.

Holders of 5% or more of SLBT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of SL Science Holding Ltd, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of SL Science Holding Ltd on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on SL Science Holding Ltd, newest first.

No Schedule 13D or 13G filings on SL Science Holding Ltd are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell SL Science Holding Ltd shares.

No Form 144 notices for SL Science Holding Ltd are on file.